Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Straumann Roxolid Multi-Center Study
NCT01842958 · View on ClinicalTrials.gov ↗
Study Summary
The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant placement. The secondary objectives will assess differences in clinical outcomes between the test and control implants, including implant success and survival, gingival recession, subject satisfaction and additional early bone level measurements.
Conditions Studied
Interventions
- DEVICE Straumann Bone Level Implants, 4.1 mm implant diameter
- DEVICE Straumann Bone Level Implants, 3.3 mm implant diameter
Study Locations (5)
California
- UCLA School of Dentistry — Los Angeles
Massachusetts
- Boston University, School of Dental Medicine — Boston
New York
- New York University College of Dentistry — New York
Texas
- Univeristy of Texas Health Science Center San Antonio — San Antonio
Washington
- University of Washington — Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842958
The ClinicalTrials.gov registry entry for NCT01842958 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institut Straumann, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Jaw, Edentulous, Partially appearing as the primary indexed condition, and to 2 interventions — of which Straumann Bone Level Implants, 4.1 mm implant diameter is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01842958 reports 5 study locations spanning 5 distinct geographic areas — top geographies include California, Massachusetts, New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01842958 about?
NCT01842958 is a clinical study titled "Straumann Roxolid Multi-Center Study". The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant ...
What is the current status of trial NCT01842958?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-03. Estimated completion is 2016-03.
What conditions does trial NCT01842958 study?
This clinical trial studies the following conditions: Jaw, Edentulous, Partially. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT01842958?
The interventions under investigation include: Straumann Bone Level Implants, 4.1 mm implant diameter (DEVICE), Straumann Bone Level Implants, 3.3 mm implant diameter (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT01842958?
This trial is sponsored by Institut Straumann, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01842958 being conducted?
This trial has 5 study locations across California, Massachusetts, New York, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.